# Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy

> **NCT07628894** · PHASE1 · NOT_YET_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 8 (estimated)

## Conditions studied

- Advanced Cutaneous Melanoma
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Metastatic Cutaneous Melanoma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Internet-Based Intervention
- **OTHER:** Medical Device Usage and Evaluation
- **PROCEDURE:** Phototherapy
- **OTHER:** Questionnaire Administration
- **BIOLOGICAL:** Therapeutic Tumor Infiltrating Lymphocytes

## Key facts

- **NCT ID:** NCT07628894
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-23
- **Primary completion:** 2027-07-05
- **Final completion:** 2027-07-05
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07628894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07628894, "Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07628894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*